The term onychomycosis refers to fungal infection of the nails whether this is a primary event or a secondary infection of a previously diseased or traumatised nail. Infection may be due to dermatophyte (ringworm, tinea unguium), yeast, or other non-dermatophyte (mould) species, and the clinical appearance may indicate the nature of the infecting organism. In paronychia chronic infection of the nail fold is most often caused by Candida species, but bacterial infection with Gram negative species such as Pseudomonas may coexist. Acute paronychia (whitlow) due to staphylococcal infection may also occur, and the presence of these bacterial infections will influence management. Invasion of the nail plate by Candida species may occur in the presence of paronychia, immune deficiency states (including chronic mucocutaneous candidiasis), Raynaud's disease, or endocrine disorders. This paper reviews the clinical features of onychomycosis and the differential diagnosis of nail dystrophy, gives the reasons for appropriate mycological investigation, and discusses guidelines for appropriate treatment on the basis of laboratory findings and particular clinical situations.
Epidemiology
Treating onychomycoses is difficult but is important because they do not resolve spontaneously. About 30% of all superficial fungal infections affect the nail. ' recent population survey of dermatophyte onychomycosis has suggested a prevalence of 2-8% for men and 2-6% for women in the United Kingdom.' Earlier surveys of swimming pools,4 schools,5 hospital patients, 6 and office workers7 have shown a prevalence of tinea pedis of 8-40%. Of those people with tinea pedis, 20-30% also have affected nails.8 This suggests that the prevalence of onychomycosis in adults could therefore be about 3-8%. This is difficult to assess, however, since some reports do not distinguish between dermatophytosis and other forms of onychomycosis or between infection of fingernails and toenails.
Toenails are more commonly infected than fingernails.' This applies particularly to dermatophyte and mould infections, whereas Candida infections are more likely to affect the fingernails and fingernail folds.'" Mixed infection can account for up to 5% of onychomycotic infections.'12 There is wide geographical and ethnic variation in the causative species, but in Britain about 5% ofcases are due to non-dermatophyte moulds such as Scopulariopsis (see box 1) and these almost exclusively affect nails. There are many cases of patients who have been inappropriately treated for years because the correct diagnosis has not been established. Nail infection due to Scopulariopsis will not respond to the standard treatments for dermatophyte or yeast onychomycosis.
The increase in foreign travel has led to the introduction of some exotic species. In addition fungi previously considered to be non-pathogenic may now be found as pathogens in patients with immune BMJ VOLUME 311 1 nails,"3 but dermatophyte infection is seldom found and is more likely to affect the toenails. Chronic paronychia due to Candida infection is commonly associated with psoriasis and eczema of the fingernails.'4 It is important to detect coexisting infection since treatment will ensure a more rapid improvement in the appearance ofthe nails in these conditions.
Mycological diagnosis
When fungal infection is suspected, specimens for confirmation of the diagnosis should be obtained before treatment is started. As mentioned above, several dermatological conditions can produce nail changes that mimic fungal infection, and these can account for apparent failure of treatment with antifungal drugs.
TAKING SPECIMENS An adequate specimen is required for microscopy and culture. Having a specimen taken should be painless apart from occasional slight discomfort when subungual specimens are taken. Figure 2 shows the appropriate sites from which nail specimens should be obtained. Scrapings taken with a blunt scalpel or clippings should be transported in a folded square of paper, preferably fastened with a paper clip, but commercial mycological packs are also available (such as Dermapak, Dermaco, Toddington, Bedfordshire, and MycoTrans, MycoTrans, Biggar, Lanarkshire).
MICROSCOPY AND CULTURE
In the laboratory 20-30% potassium hydroxide solution is added to part of the specimen to macerate the nail keratin so that the specimen can be examined for fungal elements by direct microscopy. The rest of the specimen is inoculated on to several different media to test for the presence of non-dermatophytes as well as dermatophytes and yeasts. This is important because infection with most non-dermatophyte species-such as Scopulaniopsis, Scytalidium, Fusarium, and Acremonium-will not usually respond to oral treatment.
The results of culture can be positive even if microscopy is negative, but it is more common for microscopy to be positive while culture is negative (30-50%). Specimens from nails (subungual debris and clippings) should be taken as proximally as possible since this increases the probability of obtaining a positive culture result as well as positive microscopy. Although fungal elements may be seen in material from the distal end of the toenail, the culture may be negative. This probably reflects the slow rate of toenail growth, so that the fungal elements seen are no longer viable. Subungual material may yield helpful positive culture results since dermatophyte infection is Candida species,5 but treatment needs to be continued for at least six months for fingernails and 12 months or longer for toenails. A similar cure rate for toenails can be obtained with amorolfine, but a rather better cure rate of 50% after six months is likely with affected fingernails.'0 Proximal nail disease or severe nail bed involvement is extremely unlikely to respond to topical treatment, even if this is preceded by chemical dissolution of the diseased nail with 40% urea paste.'6 Urea paste should normally be applied by a chiropodist. Nail avulsion may occasionally be necessary for non-dermatophyte (mould) disease but is undesirable since it may result in damage to the nail matrix and subsequent permanent damage to the nail. Some non-dermatophyte infections may respond to systemic treatment. When the skin is affected as well as the nails this will require treatment in its own right and, if extensive, may be an indication for systemic treatment.
Topical treatment with an imidazole cream or paint twice daily for up to six months will often cure chronic paronychia, especially when this is localised to fingernail folds, which is the common clinical situation. From a practical viewpoint, paint formulations may be easier to use than creams. Measures to reduce maceration ofthe nail folds should be incorporated into the management of such cases. The associated proximal nail dystrophy will often improve with treatment of the nail fold. Localised distal infection of the nail by Candida species requires use of Trosyl nail paint twice daily or weekly use of amorolfine nail paint. Severe Candida onychomycosis or paronychia is likely to require systemic treatment, especially since such cases are usually associated with an immune deficiency state.
SYSTEMIC TREATMENTS

Terbinafine
The allylamine terbinafine (Lamisil) is now the treatment of choice for dermatophyte onychomycosis. Terbinafine has fungicidal activity against all dermatophytes and various Candida species, including Candida parapsilosis. However, it shows only fungistatic activity against Candida albicans.'7 It is therefore inappropriate for a mixed dermatophyte and Candida albicans infection unless the C albicans infection is localised and can be treated topically. With more extensive mixed infection, itraconazole would be more appropriate.
Infection of fingernails requires terbinafine 250 mg daily for between six weeks and three months, whereas toenail infection requires treatment for three months or possibly up to six months. A repeat culture at three months may be useful in patients undergoing treatment with terbinafine, since a positive culture at this stage would indicate whether a longer course was required. From a clinical viewpoint, it may be difficult to assess whether a fingernail or toenail is completely free of infection at three months since the distal dystrophic part of the nail may not have grown out. Treatment with oral terbinafine will also clear any associated skin infection without the need for addtiional topical treatment. Although it is not yet licensed in Britain for use in young children, it may be used in children aged 12 where I carried out a research project. A slim, intelligent yet distressed European woman in her early 40s asked me for a talk. For about five years she had been hearing voices of several men and women talking to her and each other in different European languages. She resisted their instructions but thought that they influenced her body and changed her feelings. Friends' advice to "withdraw her antennas" had been helpful. Recently she had been hearing plants commenting on her thoughts and actions. These experiences had become so uncomfortable that she wanted to get rid of them. She had never mentioned them to doctors, afraid of being regarded as mad and given medicines.
She did not seem a risk to herself or others and had no features of major depression. I explained the benefits of antipsychotic medication but she declined, afraid of side effects and reduction in sensitivity. What to suggest? She decided to try meditation, painting, and gardening.
A week later the voices were worse and she found it hard to concentrate. I urged her to consider antipsychotic drugs. She felt devastated. She was determined to get rid of her experiences without medicine. She attended painting classes, meditated, and did gardening. She booked craniosacral balancing (soft bodywork) and Tibetan pulsing healing (meditative bodywork) sessions. In the following weeks she flourished. She described increasing self worth and dignity, became more lively and energetic, and the voices did not disturb her any more. She stopped gardening but maintained her progress and returned to Europe a few months later.
I felt I had not done anything for her and yet she was grateful. I regard antipsychotic drugs as a mainstay in treating psychosis. But her symptoms reduced with methods doctors tend to discount. When she left India she was not symptom free, but confident and cheerful.
Psychosis can fluctuate in severity independent of antipsychotic treatment. But why had I not seen such improvement in patients with chronic psychosis in Germany or in Britain? Do such patients avoid psychiatrists? Are they not referred or seen only once in a clinic, never to return again? Do we treat too hastily? Are we hindering improvement by reducing self respect, sensitivity, and motivation through stigma, neuroleptic medication, or side effects?
I do not expect to find an answer. Osho Commune International discourages people with mental health problems, as a visit can be destabilising and psychiatric facilities for visitors are minimal. So it is unlikely that I will have a similar experience there. I feel enriched and grateful. I became aware of treatment options which I never considered before and probably would not consider in a Western health service. I learnt to pay attention to the possibility of improvement without drugs, unusual treatments which patients may suggest, and of the value of their motivation.-KAmiAA-MAwIA MuELLER is a locum senior registrar in psychiatry in Colchester
